{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:14:47Z","timestamp":1781781287880,"version":"3.54.5"},"reference-count":124,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.mayocp.2015.08.020","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T13:02:07Z","timestamp":1448974927000},"page":"1679-1693","source":"Crossref","is-referenced-by-count":32,"title":["Hidradenitis Suppurativa"],"prefix":"10.1016","volume":"90","author":[{"given":"Carina M.","family":"Woodruff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas M.","family":"Charlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieron S.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1365-4362.1998.00414.x","article-title":"Acne inversa","volume":"37","author":"Jansen","year":"1998","journal-title":"Int J Dermatol"},{"issue":"12","key":"10.1016\/j.mayocp.2015.08.020_bib2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00007611-199812000-00003","article-title":"Hidradenitis suppurativa","volume":"91","author":"Brown","year":"1998","journal-title":"South Med J"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib3","first-page":"165","article-title":"Hidradenitis suppurativa: a disease with male predominance in Tunisia","volume":"18","author":"Mebazaa","year":"2009","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.mayocp.2015.08.020_bib4","series-title":"Hidradenitis Suppurativa","first-page":"11","article-title":"Clinical presentation","author":"Poli","year":"2006"},{"issue":"1","key":"10.1016\/j.mayocp.2015.08.020_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","article-title":"Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota","volume":"133","author":"Vazquez","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib7","first-page":"730","article-title":"Incidence of cancer among patients with hidradenitis suppurativa","volume":"137","author":"Lapins","year":"2001","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/archderm.1968.01610140036007","article-title":"Anemia associated with hidradenitis suppurativa","volume":"98","author":"Tennant","year":"1968","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.08.020_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jama.198.1.201","article-title":"Hidradenitis suppurativa: complications resulting in death","volume":"198","author":"Moschella","year":"1966","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.mayocp.2015.08.020_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1308\/003588407X209392","article-title":"Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa","volume":"89","author":"Maclean","year":"2007","journal-title":"Ann R Coll Surg Engl"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib11","first-page":"309","article-title":"Immunological studies of the arthritis of acne conglobata and hidradenitis suppurativa","volume":"2","author":"Vasey","year":"1984","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.mayocp.2015.08.020_bib12","series-title":"Apocrine Glands","author":"Hurley","year":"1979"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2340\/00015555-0866","article-title":"Psychophysical aspects of hidradenitis suppurativa","volume":"90","author":"Matusiak","year":"2010","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2340\/00015555-1082","article-title":"Psychosocial impact of hidradenitis suppurativa: a qualitative study","volume":"91","author":"Esmann","year":"2011","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","article-title":"Depression in patients with hidradenitis suppurativa","volume":"27","author":"Onderdijk","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","article-title":"Profound disturbances of sexual health in patients with acne inversa","volume":"67","author":"Kurek","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.mayocp.2015.08.020_bib17","first-page":"743","article-title":"Depression is a frequent co-morbidity in patients with acne inversa","volume":"11","author":"Kurek","year":"2013","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2230.1996.tb00145.x","article-title":"Hidradenitis suppurativa\u2014characteristics and consequences","volume":"21","author":"Jemec","year":"1996","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jaad.2009.09.021","article-title":"Hidradenitis suppurativa markedly decreases quality of life and professional activity","volume":"62","author":"Matusiak","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.08.020_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0007-1226(03)00177-2","article-title":"Hidradenitis suppurativa: pathogenesis and management","volume":"56","author":"Slade","year":"2003","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.mayocp.2015.08.020_bib21","series-title":"Dermatologic Surgery","first-page":"729","article-title":"Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach","author":"Hurley","year":"1989"},{"issue":"1","key":"10.1016\/j.mayocp.2015.08.020_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2133.2003.05390.x","article-title":"Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa","volume":"149","author":"Sartorius","year":"2003","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2014.04.001","article-title":"Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity","volume":"71","author":"Schrader","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.08.020_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaad.2009.02.013","article-title":"Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity","volume":"61","author":"Canoui-Poitrine","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib25","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/jid.2012.472","article-title":"Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study","volume":"133","author":"Canoui-Poitrine","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.08.020_bib27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.devcel.2004.09.014","article-title":"Gamma-secretase functions through Notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesis","volume":"7","author":"Pan","year":"2004","journal-title":"Dev Cell"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/jid.2012.372","article-title":"\u03b3-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis","volume":"133","author":"Pink","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"issue":"10","key":"10.1016\/j.mayocp.2015.08.020_bib29","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1038\/jid.2012.162","article-title":"Mutations in the \u03b3-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa)","volume":"132","author":"Pink","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6007","key":"10.1016\/j.mayocp.2015.08.020_bib30","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1126\/science.1196284","article-title":"Gamma-secretase gene mutations in familial acne inversa","volume":"330","author":"Wang","year":"2010","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib31","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib32","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","article-title":"Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa","volume":"186","author":"Wolk","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib33","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2133.2011.10698.x","article-title":"Adalimumab (antitumour necrosis factor-\u03b1) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex\u00a0vivo study","volume":"166","author":"van der Zee","year":"2012","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archdermatol.2011.315","article-title":"Hidradenitis suppurativa: the role of deficient cutaneous innate immunity","volume":"148","author":"Dr\u00e9no","year":"2012","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib36","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jaad.2011.07.020","article-title":"Expression of innate defense antimicrobial peptides in hidradenitis suppurativa","volume":"66","author":"Hofmann","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.08.020_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaad.2008.12.033","article-title":"Human beta-defensin-2 and psoriasin are overexpressed in lesions of acne inversa","volume":"61","author":"Schlapbach","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.mayocp.2015.08.020_bib38","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1600-0625.2012.01552.x","article-title":"Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments","volume":"21","author":"van der Zee","year":"2012","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/QCO.0b013e3283428d07","article-title":"Hidradenitis suppurativa: a review of cause and treatment","volume":"24","author":"Yazdanyar","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000018126","article-title":"Cigarette smoking as a triggering factor of hidradenitis suppurativa","volume":"198","author":"K\u00f6nig","year":"1999","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjd.13090","article-title":"Risk-factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study","volume":"171","author":"Kromann","year":"2014","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib42","first-page":"83","article-title":"Pathogenesis, clinical features and management of hidradenitis suppurativa","volume":"79","author":"Parks","year":"1997","journal-title":"Ann R Coll Surg Engl"},{"issue":"5","key":"10.1016\/j.mayocp.2015.08.020_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712.x","article-title":"What causes hidradenitis suppurativa?","volume":"17","author":"Kurzen","year":"2008","journal-title":"Exp Dermatol"},{"issue":"24-25","key":"10.1016\/j.mayocp.2015.08.020_bib44","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.lfs.2007.02.007","article-title":"Functional significance of non-neuronal acetylcholine in skin epithelia","volume":"80","author":"Hana","year":"2007","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/00015550152384209","article-title":"Neutrophil-related host response in hidradenitis suppurativa: a pilot study in patients with inactive disease","volume":"81","author":"Lapins","year":"2001","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.08.020_bib46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0736-4679(86)90214-3","article-title":"Epidemiology, pathology, and treatment of axillary hidradenitis suppurativa","volume":"4","author":"Edlich","year":"1986","journal-title":"J\u00a0Emerg Med"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib47","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2006.12.004","article-title":"Obesity and the skin: skin physiology and skin manifestations of obesity","volume":"56","author":"Yosipovitch","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib48","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1365-2133.1996.tb07942.x","article-title":"Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa","volume":"134","author":"Barth","year":"1996","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2133.1988.tb03227.x","article-title":"The symptomatology of hidradenitis suppurativa in women","volume":"119","author":"Jemec","year":"1988","journal-title":"Br J Dermatol"},{"issue":"6515","key":"10.1016\/j.mayocp.2015.08.020_bib50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/bmj.292.6515.245","article-title":"Mediation of hidradenitis suppurativa by androgens","volume":"292","author":"Mortimer","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000246246","article-title":"The bacteriology of hidradenitis suppurativa","volume":"193","author":"Jemec","year":"1996","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib52","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2340\/00015555-1841","article-title":"Bacteriology of hidradenitis suppurativa\u2014which antibiotics are the treatment of choice?","volume":"94","author":"Matusiak","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.mayocp.2015.08.020_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fphys.2012.00013","article-title":"Skin Manifestations of inflammatory bowel disease","volume":"3","author":"Huang","year":"2012","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib54","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review","volume":"60","author":"Alikhan","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.08.020_bib55","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2340\/00015555-1800","article-title":"The influence of body weight on the prevalence and severity of hidradenitis suppurativa","volume":"94","author":"Kromann","year":"2014","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib56","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/ced.12269","article-title":"Rapid resolution of hidradenitis suppurativa after bariatric surgical intervention","volume":"39","author":"Thomas","year":"2014","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.08.020_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaad.2009.08.001","article-title":"Hidradenitis suppurativa and smoking","volume":"62","author":"Simonart","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.08.020_bib58","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-4362.1983.tb02150.x","article-title":"Topical treatment of hidradenitis suppurativa with clindamycin","volume":"22","author":"Clemmensen","year":"1983","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib59","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa","volume":"39","author":"Jemec","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.mayocp.2015.08.020_bib60","first-page":"827","article-title":"Treatment experience in a local population with hidradenitis suppurativa","volume":"13","author":"Kohorst","year":"2014","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.08.020_bib61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000321716","article-title":"Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa","volume":"222","author":"Join-Lambert","year":"2011","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.mayocp.2015.08.020_bib62","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2133.2006.07155.x","article-title":"Clindamycin and rifampicin combination therapy for hidradenitis suppurativa","volume":"154","author":"Mendon\u00e7a","year":"2006","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib63","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients","volume":"219","author":"Gener","year":"2009","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.mayocp.2015.08.020_bib64","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jdv.12127","article-title":"Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients","volume":"28","author":"Bettoli","year":"2014","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000228337","article-title":"The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa","volume":"219","author":"van der Zee","year":"2009","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2310\/7750.2007.00019","article-title":"Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy","volume":"11","author":"Kraft","year":"2007","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib67","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/09546630510031403","article-title":"Hidradenitis suppurativa treated with finasteride","volume":"16","author":"Joseph","year":"2005","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib68","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2133.1986.tb05740.x","article-title":"A\u00a0double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa","volume":"115","author":"Mortimer","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mayocp.2015.08.020_bib69","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data","volume":"342","author":"Jick","year":"2011","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib70","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1046\/j.1365-2133.1999.03224.x","article-title":"Finasteride as a therapy for hidradenitis suppurativa","volume":"141","author":"Farrell","year":"1999","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib71","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamadermatol.2013.2874","article-title":"Finasteride for the treatment of hidradenitis suppurativa in children and adolescents","volume":"149","author":"Randhawa","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.08.020_bib72","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jcem-72-5-1008","article-title":"Comparison of sequential cyproterone acetate\/estrogen versus spironolactone\/oral contraceptive in the treatment of hirsutism","volume":"72","author":"O'Brien","year":"1991","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib73","doi-asserted-by":"crossref","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib74","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2015.08.020_bib75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003495-199958001-00010","article-title":"Insulin resistance, polycystic ovary syndrome and metformin","volume":"58","author":"Pugeat","year":"1999","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.mayocp.2015.08.020_bib76","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: a little help along the way","volume":"27","author":"Verdolini","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib77","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000182261","article-title":"Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment","volume":"218","author":"Soria","year":"2009","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib78","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjd.12104","article-title":"Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review","volume":"168","author":"Blok","year":"2013","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.08.020_bib79","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2010.10071.x","article-title":"Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?","volume":"164","author":"Boer","year":"2011","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib80","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000100883","article-title":"Hidradenitis suppurativa and zinc: a new therapeutic approach","volume":"214","author":"Brocard","year":"2007","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib81","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/09546634.2012.683767","article-title":"Long-term efficacy of infliximab in hidradenitis suppurativa","volume":"23","author":"Paradela","year":"2012","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib82","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib83","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2340\/00015555-0747","article-title":"Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors","volume":"89","author":"Haslund","year":"2009","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib84","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/09546634.2011.571657","article-title":"Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa","volume":"23","author":"van Rappard","year":"2012","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib85","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","article-title":"A\u00a0double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa","volume":"165","author":"Miller","year":"2011","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.mayocp.2015.08.020_bib86","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.mayocp.2015.08.020_bib87","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1365-4632.2010.04638.x","article-title":"Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy","volume":"49","author":"Arenbergerova","year":"2010","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib88","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2133.2007.08372.x","article-title":"An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa","volume":"158","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib89","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1600-0625.2009.00967.x","article-title":"Long-term efficacy of\u00a0etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial","volume":"19","author":"Pelekanou","year":"2010","journal-title":"Exp Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib90","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2133.2005.07067.x","article-title":"Etanercept: effective in the management of hidradenitis suppurativa","volume":"154","author":"Cusack","year":"2006","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.08.020_bib91","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archdermatol.2010.72","article-title":"Treatment of hidradenitis suppurativa with etanercept injection","volume":"146","author":"Adams","year":"2010","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.08.020_bib92","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/apt.12624","article-title":"Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-\u03b1 therapy in inflammatory bowel disease","volume":"39","author":"Williams","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib93","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/annrheumdis-2013-204575","article-title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis","volume":"73","author":"Ramiro","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib94","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaad.2013.09.044","article-title":"An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa","volume":"70","author":"Leslie","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib95","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2340\/00015555-1229","article-title":"Management of recalcitrant hidradenitis suppurativa with ustekinumab","volume":"92","author":"Sharon","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.mayocp.2015.08.020_bib96","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1468-3083.2011.04123.x","article-title":"Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa","volume":"26","author":"Gulliver","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.mayocp.2015.08.020_bib97","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ad.2013.09.011","article-title":"Ustekinumab for hidradenitis suppurativa: a case report","volume":"105","author":"Santos-P\u00e9rez","year":"2014","journal-title":"Actas Dermosifiliogr"},{"issue":"10, pt 2","key":"10.1016\/j.mayocp.2015.08.020_bib98","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001050170015","volume":"52","author":"Hofer","year":"2001","journal-title":"Hautarzt"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib99","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000329023","article-title":"Dapsone therapy for hidradenitis suppurativa: a series of 24 patients","volume":"222","author":"Yazdanyar","year":"2011","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/09546630600830588","article-title":"Hidradenitis suppurativa treated with dapsone: a case series of five patients","volume":"17","author":"Kaur","year":"2006","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"5","key":"10.1016\/j.mayocp.2015.08.020_bib101","first-page":"289P","article-title":"Cyclosporin-responsive hidradenitis suppurativa","volume":"88","author":"Buckley","year":"1995","journal-title":"J\u00a0R Soc Med"},{"issue":"1","key":"10.1016\/j.mayocp.2015.08.020_bib102","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2230.2005.01983.x","article-title":"Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin","volume":"31","author":"Rose","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib103","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archderm.1990.01670270071012","article-title":"Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses: a clinical and immunopathologic analysis","volume":"126","author":"Gupta","year":"1990","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib104","first-page":"367","article-title":"Reactive arthritis associated with hidradenitis suppurativa","volume":"101","author":"Marquardt","year":"2009","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2230.1999.00451.x","article-title":"Severe vulval apocrine acne successfully treated with prednisolone and isotretinoin","volume":"24","author":"Fearfield","year":"1999","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.08.020_bib106","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/01.prs.0000184354.32111.dc","article-title":"Treatment of hidradenitis suppurativa with botulinum toxin A","volume":"116","author":"O'Reilly","year":"2005","journal-title":"Plast Reconstr Surg"},{"issue":"8","key":"10.1016\/j.mayocp.2015.08.020_bib107","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1524-4725.2009.01231.x","article-title":"Prepubertal hidradenitis suppurativa successfully treated with botulinum toxin A","volume":"35","author":"Feito-Rodr\u00edguez","year":"2009","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib108","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2009.07.048","article-title":"Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser","volume":"62","author":"Mahmoud","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.mayocp.2015.08.020_bib109","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1524-4725.2009.01214.x","article-title":"Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser","volume":"35","author":"Tierney","year":"2009","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib110","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1524-4725.2009.01427.x","article-title":"Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization","volume":"36","author":"Hazen","year":"2010","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib111","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1067\/mjd.2002.124601","article-title":"Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa","volume":"47","author":"Lapins","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.08.020_bib112","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2133.1994.tb08559.x","article-title":"Surgical treatment of chronic hidradenitis suppurativa: CO2 laser stripping-secondary intention technique","volume":"131","author":"Lapins","year":"1994","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib113","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1365-2133.2008.08932.x","article-title":"Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser","volume":"159","author":"Madan","year":"2008","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib114","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0190-9622(96)90441-7","article-title":"Treatment of hidradenitis suppurativa with carbon dioxide laser excision and second-intention healing","volume":"34","author":"Finley","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jaad.2009.12.018","article-title":"Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions","volume":"63","author":"van der Zee","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.mayocp.2015.08.020_bib116","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/j.1524-4725.2010.01763.x","article-title":"Surgical treatment of hidradenitis suppurativa: experiences and recommendations","volume":"36","author":"Bieniek","year":"2010","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib117","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00000637-200112000-00010","article-title":"Experience with surgical treatment of hidradenitis suppurativa","volume":"47","author":"Tanaka","year":"2001","journal-title":"Ann Plast Surg"},{"issue":"7","key":"10.1016\/j.mayocp.2015.08.020_bib118","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1524-4725.2000.00043.x","article-title":"Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa","volume":"26","author":"Rompel","year":"2000","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib119","first-page":"835","article-title":"Surgical approach to extensive hidradenitis suppurativa","volume":"37","author":"B\u00fcy\u00fcka\u015fik","year":"2011","journal-title":"Dermatol Surg"},{"issue":"11","key":"10.1016\/j.mayocp.2015.08.020_bib120","doi-asserted-by":"crossref","first-page":"20616","DOI":"10.5070\/D31911020616","article-title":"Treatment of hidradenitis suppurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine","volume":"19","author":"Scheinfeld","year":"2013","journal-title":"Dermatol Online J"},{"issue":"6","key":"10.1016\/j.mayocp.2015.08.020_bib121","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2230.2002.11125.x","article-title":"Methotrexate is of limited value in the treatment of hidradenitis suppurativa","volume":"27","author":"Jemec","year":"2002","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.08.020_bib122","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/rheumatology\/ket260","article-title":"The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases","volume":"53","author":"Jani","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.mayocp.2015.08.020_bib123","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.clindermatol.2013.11.006","article-title":"Hidradenitis suppurativa (acne inversa) as a systemic disease","volume":"32","author":"Dessinioti","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.mayocp.2015.08.020_bib124","doi-asserted-by":"crossref","unstructured":"Yadav S, Singh S, Edakkanambeth Varayil J, et\u00a0al. Hidradenitis suppurativa in patients with inflammatory bowel disease: a population-based cohort study in Olmsted County, Minnesota [published online ahead of print May 5, 2015]. Clin Gastroenterol Hepatol. doi:10.1016\/j.cgh.2015.04.173.","DOI":"10.1016\/j.cgh.2015.04.173"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619615007119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619615007119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T23:27:42Z","timestamp":1653694062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619615007119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":124,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0025619615007119"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2015.08.020","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}